Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serial monitoring of circulating tumour DNA on clinical outcome in myelodysplastic syndromes and acute myeloid leukaemia

1 Jul 2023

Abstract excerpt

Diagnostic bone marrow (BM) DNA and matched plasma-derived circulating tumour DNA (ctDNA) demonstrated excellent correlations in myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML),1-4 and dynamic ctDNA monitoring contributes to predict relapse in MDS and AML patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT).5 However, few researches are reported on the application...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Cancer Genomics and Diagnostics
Share to Hematopoietic Stem Cell Transplantation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37491737
DOI: 10.1002/ctm2.1349

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serial monitoring of circulating tumour DNA on clinical outcome in myelodysplastic syndromes and acute myeloid leukaemiaPMID 37491737Read ↗

Prognostic impact of circulating tumor DNA status post–allogeneic hematopoietic stem cell transplantation in AML and MDSSemantic proximity Read ↗

Monitoring molecular changes in the management of myelodysplastic syndromes.Semantic proximity Read ↗

Molecular disease monitoring using circulating tumor DNA in myelodysplastic syndromes.Semantic proximity Read ↗

Real-Time Molecular Monitoring in Acute Myeloid Leukemia With Circulating Tumor DNASemantic proximity Read ↗

Prognostic significance of serial molecular annotation in myelodysplastic syndromes (MDS) and secondary acute myeloid leukemia (sAML).Semantic proximity Read ↗

Dynamic changes in the clonal structure of MDS and AML in response to epigenetic therapy.Semantic proximity Read ↗

Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AMLSemantic proximity Read ↗

Unique single-nucleotide variations, insertions/deletions and copy number variations in myelodysplastic syndrome during treatment resistance and progression revealed by a single-cell DNA sequencing platformSemantic proximity Read ↗

Single-Nucleotide Variations, Insertions/Deletions and Copy Number Variations in Myelodysplastic Syndrome during Disease Progression Revealed by a Single-Cell DNA Sequencing Platform.Semantic proximity Read ↗

Using peripheral blood circulating DNAs to detect CpG global methylation status and genetic mutations in patients with myelodysplastic syndrome.Semantic proximity Read ↗

Dynamic changes in longitudinal circulating tumour DNA profile during metastatic colorectal cancer treatment.Semantic proximity Read ↗

Simultaneous Monitoring of Mutation and Chimerism Using Next-Generation Sequencing in Myelodysplastic SyndromeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.